Patent · US Expired

Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof

US5639622A · kind A · utility

5Cited by

2References

6Claims

0Family size

Assignee

Behringwerke Aktiengesellschaft · DE

Inventors

Klaus Bosslet · Marburg, DE
Bernhard Auerbach · Marburg, DE
Helmut Peters · Marburg, DE

Key dates

Filing date	Jun 7, 1995
Grant date	Jun 17, 1997
Priority date	—
Expiry date	Jun 7, 2015

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to monoclonal antibodies (MAbs) and fragments thereof which bind to defined tumor-associated antigens, principally of small cell lung carcinoma (SCLC), of melanoma, of neuroblastoma and other tumors of neuroectodermal origin, to hybridoma cell lines for the preparation thereof, and to the antigens which can be defined and/or isolated with the aid of these antibodies or antibody fragments. The antibodies, antibody fragments and antigens can be used as diagnostic. aid, active substance or active substance carrier.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.